3rd generation glp 1 agonist Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Science's 2023 Breakthrough: GLP-1R Agonists
Description
Wharton, S
Physiol Behav (2008) 94(5):6704
2 The American Association of Clinical Endocrinologists and American College of Endocrinology 2015 guideline does, however, give preference to GLP-1RA and SGLT2-I over older medication classes including SU and TZD
In the central nervous system, GLP-1 receptors are located in the hypothalamus, which is involved in regulating food intake [24, 29, 30]
Neeland IJ, Marso SP, Ayers CR, et al
Clinical trials show weight losses of ~6%16%
